Close Menu

product launch

Translational informatics company Paradigm4's new Reveal: SingleCell app is built on its core SciDB platform that supports fast querying of large multiomic datasets.

Targeted at drug development and clinical trials, the firm's new system allows the simultaneous collection of single-cell DNA and surface protein data.

The startup has launched oncology and pulmonology beta tests at five US health systems, with help from precision health firm mProbe and several pharma partners.

The new CompStor Insight combines hardware and software in one plug-and-play package and complements the vendor's Novos DNA assembly tool.

The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.